|
Market Cap (5-Jun) $18,417,672 (949th) |
Close (30-Jun) $0.005 |
Volume (30-Jun) 14,697,042 |
Shortsold (2-Apr) 218 (0.00%) (630th) |
|
52w High $9.00 |
52w Low $0.300 |
P/E 14.90 |
EPS -3.21 |
MXC released this announcement to the ASX on 18 October 2022, 10:15. The announcement is not marked as price sensitive, and is 86 page(s) in length and 4.06MB in size.
You can view all announcements from MXC and see how they appear on a price chart on the announcements page.
At the date of this announcement, MXC was 0.043% short sold according to ASIC data. It was ranked the 544th most shorted stock on the ASX. It remains ranked 630th as of the latest reported data (02 April 2024).
| Other Recent Announcements from MXC | |
|---|---|
| Details of Company Address | 30 June 2023, 17:34 |
| Company Update | 30 June 2023, 17:24 |
| Results of Meeting | 29 June 2023, 18:43 |
| Annual Report to shareholders | 18 October 2022, 10:15 |
| Notice of Annual General Meeting/Proxy Form | 18 October 2022, 10:12 |
| Results of Meeting | 6 October 2022, 8:14 |
| Appointment of UK Corporate Advisor and Company Update | 4 October 2022, 17:09 |
You must be logged in to post a reply.
MGC Pharmaceuticals 